Skip to main content
  • Login
  • Contact
  • Subscribe
  • Advertise With Us

Search form

Home

The Pilot News

Plymouth weather info

  • Home
    • Forms
  • News
    • Local News
    • The Leader of Starke County
    • Culver Citizen
    • Business News
  • Sports
  • Obituaries
  • Classifieds
    • Place an Ad
    • Classified Display Ads
  • Entertainment
    • Calendar
    • Best Of
    • Special Sections
    • Talking About...
    • Games
  • Photos
  • Videos
Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Axovant Sciences Ltd (NQ: AXGT)
7.790   +0.020 (+0.26%)
Streaming Delayed Price  /  Updated: 1:59 PM EDT, Sep 23, 2019  /  Add to My Watchlist      
View: Quote
Overview
Detailed Quote
Charting
Historical Prices
 News
All News
Press Releases
Related Stories
Blogs
 Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 27,619
Open 7.800
Bid (Size) 7.690 (4)
Ask (Size) 7.800 (4)
Prev. Close 7.770
Today's Range 7.650 - 8.000
52wk Range 1.010 - 9.250
Shares Outstanding N/A
Dividend Yield N/A
Performance
YTD
+571.55%
+571.55%
1 Month
+21.34%
+21.34%
3 Month
+21.53%
+21.53%
6 Month
+472.79%
+472.79%
1 Year
+571.55%
+571.55%
Top News
More News
Axovant Announces Corporate Updates and Financial Results for First Fiscal Quarter Ended June 30, 2019
August 09, 2019
from GlobeNewswire News Releases
Axovant Appoints David Nassif as Chief Financial Officer and Expands Board of Directors
July 01, 2019
Axovant Gene Therapies Ltd. (NASDAQ: AXGT), a clinical-stage company developing innovative gene therapies, today announced the appointment of David Nassif as Chief Financial Officer, effective July 1,... Read More
from GlobeNewswire News Releases
More News
Read More
Axovant Announces Poster Presentations at the 5th Congress of the European Academy of Neurology
June 24, 2019
from GlobeNewswire News Releases
Axovant and Yposkesi Sign Strategic Gene Therapy Development and Manufacturing Partnership
June 20, 2019
from GlobeNewswire News Releases
Axovant Analyst Turns Bullish Ahead Of Q4 Gene Therapy Data Readouts
August 12, 2019
category Biotech , Baird , Benzinga , and 9 more.
from Benzinga
Mid-Afternoon Market Update: ContraVir Pharmaceuticals Surges On Positive FDA Feedback; Inuvo Shares Fall
June 21, 2019
category TUSK , Benzinga , PBF , and 17 more.
from Benzinga
Mid-Day Market Update: Crude Oil Up 1%; Axovant Gene Therapies Shares Spike Higher
June 21, 2019
category LKSD , INUV , EPSN , and 17 more.
from Benzinga
Mid-Morning Market Update: Markets Edge Lower; CarMax Tops Q1 Expectations
June 21, 2019
category Mid/Morning Market Update , Benzinga , Eurozone , and 15 more.
from Benzinga
Axovant Strikes Gene Therapy Manufacturing Partnership With CDMO
June 20, 2019
category Trading Ideas , Market News , Contracts , and 6 more.
from Benzinga
Benzinga's Top Upgrades, Downgrades For August 12, 2019
August 12, 2019
category Benzinga , PHR , ORCC , and 40 more.
from Benzinga
55 Biggest Movers From Yesterday
July 12, 2019
category Market News , AMRX , CDZI , and 64 more.
from Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Copyright © 2019 The Pilot News | 214 N. Michigan | Plymouth, IN 46563 | (574) 936-3101 • 800-933-0356
All property rights for the entire contents of this publication shall be the property of The Pilot News.
No part hereof may be reproduced without prior written consent.
Privacy and Terms of Use


Site Design, Programming & Development by Surf New Media